Regeneron Pharmaceuticals
REGN
REGN
1,222 hedge funds and large institutions have $48.9B invested in Regeneron Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 170 funds opening new positions, 478 increasing their positions, 412 reducing their positions, and 112 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 1,194 → 1,222 (+28)
4% more capital invested
Capital invested by funds: $46.8B → $48.9B (+$2.03B)
0.55% less ownership
Funds ownership: 84% → 83.45% (-0.55%)
Holders
1,222
Holding in Top 10
21
Calls
$1.5B
Puts
$1.04B
Top Buyers
| 1 | +$407M | |
| 2 | +$341M | |
| 3 | +$230M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$188M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$139M |
Top Sellers
| 1 | -$1.29B | |
| 2 | -$782M | |
| 3 | -$253M | |
| 4 |
BlackRock
New York
|
-$247M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$211M |
